Medical Care
Global Allogeneic Stem Cell Transplantation Market Research Report 2025
- May 12, 25
- ID: 236160
- Pages: 88
- Figures: 81
- Views: 6
The global market for Allogeneic Stem Cell Transplantation was valued at US$ 1117 million in the year 2024 and is projected to reach a revised size of US$ 1670 million by 2031, growing at a CAGR of 6.0% during the forecast period.
North American market for Allogeneic Stem Cell Transplantation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Allogeneic Stem Cell Transplantation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Allogeneic Stem Cell Transplantation in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Allogeneic Stem Cell Transplantation include Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., Fate Therapeutics Inc., Cynata Therapeutics Limited, Kiadis Pharma N.V, Takeda Pharmaceutical Company Limited, JCR Pharmaceuticals Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Transplantation.
The Allogeneic Stem Cell Transplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allogeneic Stem Cell Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cell Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mesoblast Limited
Gamida Cell Ltd.
Novartis International AG
Cellectis SA
Magenta Therapeutics Inc.
Fate Therapeutics Inc.
Cynata Therapeutics Limited
Kiadis Pharma N.V
Takeda Pharmaceutical Company Limited
JCR Pharmaceuticals Co., Ltd.
Pluristem Therapeutics Inc.
Celularity Inc.
Lineage Cell Therapeutics Inc.
Nohla Therapeutics Inc.
Orchard Therapeutics Plc
Segment by Type
Unmodified Stem Cell Transplant
T-cell Depleted Transplant
Cord Blood Transplant
Donor Lymphocyte Infusion
Segment by Application
Hospital
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cell Transplantation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Allogeneic Stem Cell Transplantation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Allogeneic Stem Cell Transplantation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Allogeneic Stem Cell Transplantation in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Allogeneic Stem Cell Transplantation include Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., Fate Therapeutics Inc., Cynata Therapeutics Limited, Kiadis Pharma N.V, Takeda Pharmaceutical Company Limited, JCR Pharmaceuticals Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cell Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cell Transplantation.
The Allogeneic Stem Cell Transplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allogeneic Stem Cell Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allogeneic Stem Cell Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mesoblast Limited
Gamida Cell Ltd.
Novartis International AG
Cellectis SA
Magenta Therapeutics Inc.
Fate Therapeutics Inc.
Cynata Therapeutics Limited
Kiadis Pharma N.V
Takeda Pharmaceutical Company Limited
JCR Pharmaceuticals Co., Ltd.
Pluristem Therapeutics Inc.
Celularity Inc.
Lineage Cell Therapeutics Inc.
Nohla Therapeutics Inc.
Orchard Therapeutics Plc
Segment by Type
Unmodified Stem Cell Transplant
T-cell Depleted Transplant
Cord Blood Transplant
Donor Lymphocyte Infusion
Segment by Application
Hospital
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allogeneic Stem Cell Transplantation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Unmodified Stem Cell Transplant
1.2.3 T-cell Depleted Transplant
1.2.4 Cord Blood Transplant
1.2.5 Donor Lymphocyte Infusion
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Transplantation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Transplantation Market Perspective (2020-2031)
2.2 Global Allogeneic Stem Cell Transplantation Growth Trends by Region
2.2.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allogeneic Stem Cell Transplantation Historic Market Size by Region (2020-2025)
2.2.3 Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2026-2031)
2.3 Allogeneic Stem Cell Transplantation Market Dynamics
2.3.1 Allogeneic Stem Cell Transplantation Industry Trends
2.3.2 Allogeneic Stem Cell Transplantation Market Drivers
2.3.3 Allogeneic Stem Cell Transplantation Market Challenges
2.3.4 Allogeneic Stem Cell Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue (2020-2025)
3.1.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Players (2020-2025)
3.2 Global Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allogeneic Stem Cell Transplantation Revenue
3.4 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Transplantation Revenue in 2024
3.5 Global Key Players of Allogeneic Stem Cell Transplantation Head office and Area Served
3.6 Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
3.7 Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cell Transplantation Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Type (2020-2025)
4.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2026-2031)
5 Allogeneic Stem Cell Transplantation Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Application (2020-2025)
5.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allogeneic Stem Cell Transplantation Market Size (2020-2031)
6.2 North America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
6.4 North America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Transplantation Market Size (2020-2031)
7.2 Europe Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
7.4 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size (2020-2031)
8.2 Asia-Pacific Allogeneic Stem Cell Transplantation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025)
8.4 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cell Transplantation Market Size (2020-2031)
9.2 Latin America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
9.4 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size (2020-2031)
10.2 Middle East & Africa Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
10.4 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast Limited
11.1.1 Mesoblast Limited Company Details
11.1.2 Mesoblast Limited Business Overview
11.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Introduction
11.1.4 Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.1.5 Mesoblast Limited Recent Development
11.2 Gamida Cell Ltd.
11.2.1 Gamida Cell Ltd. Company Details
11.2.2 Gamida Cell Ltd. Business Overview
11.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Introduction
11.2.4 Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.2.5 Gamida Cell Ltd. Recent Development
11.3 Novartis International AG
11.3.1 Novartis International AG Company Details
11.3.2 Novartis International AG Business Overview
11.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Introduction
11.3.4 Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.3.5 Novartis International AG Recent Development
11.4 Cellectis SA
11.4.1 Cellectis SA Company Details
11.4.2 Cellectis SA Business Overview
11.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Introduction
11.4.4 Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.4.5 Cellectis SA Recent Development
11.5 Magenta Therapeutics Inc.
11.5.1 Magenta Therapeutics Inc. Company Details
11.5.2 Magenta Therapeutics Inc. Business Overview
11.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.5.4 Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.5.5 Magenta Therapeutics Inc. Recent Development
11.6 Fate Therapeutics Inc.
11.6.1 Fate Therapeutics Inc. Company Details
11.6.2 Fate Therapeutics Inc. Business Overview
11.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.6.4 Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.6.5 Fate Therapeutics Inc. Recent Development
11.7 Cynata Therapeutics Limited
11.7.1 Cynata Therapeutics Limited Company Details
11.7.2 Cynata Therapeutics Limited Business Overview
11.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Introduction
11.7.4 Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.7.5 Cynata Therapeutics Limited Recent Development
11.8 Kiadis Pharma N.V
11.8.1 Kiadis Pharma N.V Company Details
11.8.2 Kiadis Pharma N.V Business Overview
11.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Introduction
11.8.4 Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.8.5 Kiadis Pharma N.V Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Details
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Details
11.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Introduction
11.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.11 Pluristem Therapeutics Inc.
11.11.1 Pluristem Therapeutics Inc. Company Details
11.11.2 Pluristem Therapeutics Inc. Business Overview
11.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.11.4 Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.11.5 Pluristem Therapeutics Inc. Recent Development
11.12 Celularity Inc.
11.12.1 Celularity Inc. Company Details
11.12.2 Celularity Inc. Business Overview
11.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Introduction
11.12.4 Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.12.5 Celularity Inc. Recent Development
11.13 Lineage Cell Therapeutics Inc.
11.13.1 Lineage Cell Therapeutics Inc. Company Details
11.13.2 Lineage Cell Therapeutics Inc. Business Overview
11.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.13.4 Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.13.5 Lineage Cell Therapeutics Inc. Recent Development
11.14 Nohla Therapeutics Inc.
11.14.1 Nohla Therapeutics Inc. Company Details
11.14.2 Nohla Therapeutics Inc. Business Overview
11.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.14.4 Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.14.5 Nohla Therapeutics Inc. Recent Development
11.15 Orchard Therapeutics Plc
11.15.1 Orchard Therapeutics Plc Company Details
11.15.2 Orchard Therapeutics Plc Business Overview
11.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Introduction
11.15.4 Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.15.5 Orchard Therapeutics Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Unmodified Stem Cell Transplant
1.2.3 T-cell Depleted Transplant
1.2.4 Cord Blood Transplant
1.2.5 Donor Lymphocyte Infusion
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Transplantation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Transplantation Market Perspective (2020-2031)
2.2 Global Allogeneic Stem Cell Transplantation Growth Trends by Region
2.2.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allogeneic Stem Cell Transplantation Historic Market Size by Region (2020-2025)
2.2.3 Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2026-2031)
2.3 Allogeneic Stem Cell Transplantation Market Dynamics
2.3.1 Allogeneic Stem Cell Transplantation Industry Trends
2.3.2 Allogeneic Stem Cell Transplantation Market Drivers
2.3.3 Allogeneic Stem Cell Transplantation Market Challenges
2.3.4 Allogeneic Stem Cell Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue (2020-2025)
3.1.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Players (2020-2025)
3.2 Global Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allogeneic Stem Cell Transplantation Revenue
3.4 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Transplantation Revenue in 2024
3.5 Global Key Players of Allogeneic Stem Cell Transplantation Head office and Area Served
3.6 Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
3.7 Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cell Transplantation Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Type (2020-2025)
4.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2026-2031)
5 Allogeneic Stem Cell Transplantation Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Application (2020-2025)
5.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allogeneic Stem Cell Transplantation Market Size (2020-2031)
6.2 North America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
6.4 North America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Transplantation Market Size (2020-2031)
7.2 Europe Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
7.4 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size (2020-2031)
8.2 Asia-Pacific Allogeneic Stem Cell Transplantation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025)
8.4 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cell Transplantation Market Size (2020-2031)
9.2 Latin America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
9.4 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size (2020-2031)
10.2 Middle East & Africa Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025)
10.4 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast Limited
11.1.1 Mesoblast Limited Company Details
11.1.2 Mesoblast Limited Business Overview
11.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Introduction
11.1.4 Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.1.5 Mesoblast Limited Recent Development
11.2 Gamida Cell Ltd.
11.2.1 Gamida Cell Ltd. Company Details
11.2.2 Gamida Cell Ltd. Business Overview
11.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Introduction
11.2.4 Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.2.5 Gamida Cell Ltd. Recent Development
11.3 Novartis International AG
11.3.1 Novartis International AG Company Details
11.3.2 Novartis International AG Business Overview
11.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Introduction
11.3.4 Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.3.5 Novartis International AG Recent Development
11.4 Cellectis SA
11.4.1 Cellectis SA Company Details
11.4.2 Cellectis SA Business Overview
11.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Introduction
11.4.4 Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.4.5 Cellectis SA Recent Development
11.5 Magenta Therapeutics Inc.
11.5.1 Magenta Therapeutics Inc. Company Details
11.5.2 Magenta Therapeutics Inc. Business Overview
11.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.5.4 Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.5.5 Magenta Therapeutics Inc. Recent Development
11.6 Fate Therapeutics Inc.
11.6.1 Fate Therapeutics Inc. Company Details
11.6.2 Fate Therapeutics Inc. Business Overview
11.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.6.4 Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.6.5 Fate Therapeutics Inc. Recent Development
11.7 Cynata Therapeutics Limited
11.7.1 Cynata Therapeutics Limited Company Details
11.7.2 Cynata Therapeutics Limited Business Overview
11.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Introduction
11.7.4 Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.7.5 Cynata Therapeutics Limited Recent Development
11.8 Kiadis Pharma N.V
11.8.1 Kiadis Pharma N.V Company Details
11.8.2 Kiadis Pharma N.V Business Overview
11.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Introduction
11.8.4 Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.8.5 Kiadis Pharma N.V Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Details
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Details
11.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Introduction
11.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.11 Pluristem Therapeutics Inc.
11.11.1 Pluristem Therapeutics Inc. Company Details
11.11.2 Pluristem Therapeutics Inc. Business Overview
11.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.11.4 Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.11.5 Pluristem Therapeutics Inc. Recent Development
11.12 Celularity Inc.
11.12.1 Celularity Inc. Company Details
11.12.2 Celularity Inc. Business Overview
11.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Introduction
11.12.4 Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.12.5 Celularity Inc. Recent Development
11.13 Lineage Cell Therapeutics Inc.
11.13.1 Lineage Cell Therapeutics Inc. Company Details
11.13.2 Lineage Cell Therapeutics Inc. Business Overview
11.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.13.4 Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.13.5 Lineage Cell Therapeutics Inc. Recent Development
11.14 Nohla Therapeutics Inc.
11.14.1 Nohla Therapeutics Inc. Company Details
11.14.2 Nohla Therapeutics Inc. Business Overview
11.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.14.4 Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.14.5 Nohla Therapeutics Inc. Recent Development
11.15 Orchard Therapeutics Plc
11.15.1 Orchard Therapeutics Plc Company Details
11.15.2 Orchard Therapeutics Plc Business Overview
11.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Introduction
11.15.4 Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025)
11.15.5 Orchard Therapeutics Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Unmodified Stem Cell Transplant
Table 3. Key Players of T-cell Depleted Transplant
Table 4. Key Players of Cord Blood Transplant
Table 5. Key Players of Donor Lymphocyte Infusion
Table 6. Global Allogeneic Stem Cell Transplantation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Allogeneic Stem Cell Transplantation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Allogeneic Stem Cell Transplantation Market Share by Region (2020-2025)
Table 10. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Transplantation Market Share by Region (2026-2031)
Table 12. Allogeneic Stem Cell Transplantation Market Trends
Table 13. Allogeneic Stem Cell Transplantation Market Drivers
Table 14. Allogeneic Stem Cell Transplantation Market Challenges
Table 15. Allogeneic Stem Cell Transplantation Market Restraints
Table 16. Global Allogeneic Stem Cell Transplantation Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Allogeneic Stem Cell Transplantation Market Share by Players (2020-2025)
Table 18. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2024)
Table 19. Ranking of Global Top Allogeneic Stem Cell Transplantation Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Transplantation Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Allogeneic Stem Cell Transplantation, Headquarters and Area Served
Table 22. Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
Table 23. Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Allogeneic Stem Cell Transplantation Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2020-2025)
Table 27. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2026-2031)
Table 29. Global Allogeneic Stem Cell Transplantation Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2020-2025)
Table 31. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2026-2031)
Table 33. North America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 48. Mesoblast Limited Company Details
Table 49. Mesoblast Limited Business Overview
Table 50. Mesoblast Limited Allogeneic Stem Cell Transplantation Product
Table 51. Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 52. Mesoblast Limited Recent Development
Table 53. Gamida Cell Ltd. Company Details
Table 54. Gamida Cell Ltd. Business Overview
Table 55. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product
Table 56. Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 57. Gamida Cell Ltd. Recent Development
Table 58. Novartis International AG Company Details
Table 59. Novartis International AG Business Overview
Table 60. Novartis International AG Allogeneic Stem Cell Transplantation Product
Table 61. Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 62. Novartis International AG Recent Development
Table 63. Cellectis SA Company Details
Table 64. Cellectis SA Business Overview
Table 65. Cellectis SA Allogeneic Stem Cell Transplantation Product
Table 66. Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 67. Cellectis SA Recent Development
Table 68. Magenta Therapeutics Inc. Company Details
Table 69. Magenta Therapeutics Inc. Business Overview
Table 70. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 71. Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 72. Magenta Therapeutics Inc. Recent Development
Table 73. Fate Therapeutics Inc. Company Details
Table 74. Fate Therapeutics Inc. Business Overview
Table 75. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 76. Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 77. Fate Therapeutics Inc. Recent Development
Table 78. Cynata Therapeutics Limited Company Details
Table 79. Cynata Therapeutics Limited Business Overview
Table 80. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product
Table 81. Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 82. Cynata Therapeutics Limited Recent Development
Table 83. Kiadis Pharma N.V Company Details
Table 84. Kiadis Pharma N.V Business Overview
Table 85. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product
Table 86. Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 87. Kiadis Pharma N.V Recent Development
Table 88. Takeda Pharmaceutical Company Limited Company Details
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product
Table 91. Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Limited Recent Development
Table 93. JCR Pharmaceuticals Co., Ltd. Company Details
Table 94. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 95. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product
Table 96. JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 97. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 98. Pluristem Therapeutics Inc. Company Details
Table 99. Pluristem Therapeutics Inc. Business Overview
Table 100. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 101. Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 102. Pluristem Therapeutics Inc. Recent Development
Table 103. Celularity Inc. Company Details
Table 104. Celularity Inc. Business Overview
Table 105. Celularity Inc. Allogeneic Stem Cell Transplantation Product
Table 106. Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 107. Celularity Inc. Recent Development
Table 108. Lineage Cell Therapeutics Inc. Company Details
Table 109. Lineage Cell Therapeutics Inc. Business Overview
Table 110. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 111. Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 112. Lineage Cell Therapeutics Inc. Recent Development
Table 113. Nohla Therapeutics Inc. Company Details
Table 114. Nohla Therapeutics Inc. Business Overview
Table 115. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 116. Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 117. Nohla Therapeutics Inc. Recent Development
Table 118. Orchard Therapeutics Plc Company Details
Table 119. Orchard Therapeutics Plc Business Overview
Table 120. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product
Table 121. Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 122. Orchard Therapeutics Plc Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Allogeneic Stem Cell Transplantation Picture
Figure 2. Global Allogeneic Stem Cell Transplantation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Allogeneic Stem Cell Transplantation Market Share by Type: 2024 VS 2031
Figure 4. Unmodified Stem Cell Transplant Features
Figure 5. T-cell Depleted Transplant Features
Figure 6. Cord Blood Transplant Features
Figure 7. Donor Lymphocyte Infusion Features
Figure 8. Global Allogeneic Stem Cell Transplantation Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Allogeneic Stem Cell Transplantation Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Ambulatory Surgical Center Case Studies
Figure 12. Others Case Studies
Figure 13. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 14. Global Allogeneic Stem Cell Transplantation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Allogeneic Stem Cell Transplantation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Allogeneic Stem Cell Transplantation Market Share by Region: 2024 VS 2031
Figure 17. Global Allogeneic Stem Cell Transplantation Market Share by Players in 2024
Figure 18. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Transplantation Revenue in 2024
Figure 20. North America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 22. United States Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 26. Germany Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Allogeneic Stem Cell Transplantation Market Share by Region (2020-2031)
Figure 34. China Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 42. Mexico Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 46. Turkey Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Mesoblast Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 50. Gamida Cell Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 51. Novartis International AG Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 52. Cellectis SA Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 53. Magenta Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 54. Fate Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 55. Cynata Therapeutics Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 56. Kiadis Pharma N.V Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 57. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 58. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 59. Pluristem Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 60. Celularity Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 61. Lineage Cell Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 62. Nohla Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 63. Orchard Therapeutics Plc Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Unmodified Stem Cell Transplant
Table 3. Key Players of T-cell Depleted Transplant
Table 4. Key Players of Cord Blood Transplant
Table 5. Key Players of Donor Lymphocyte Infusion
Table 6. Global Allogeneic Stem Cell Transplantation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Allogeneic Stem Cell Transplantation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Allogeneic Stem Cell Transplantation Market Share by Region (2020-2025)
Table 10. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Transplantation Market Share by Region (2026-2031)
Table 12. Allogeneic Stem Cell Transplantation Market Trends
Table 13. Allogeneic Stem Cell Transplantation Market Drivers
Table 14. Allogeneic Stem Cell Transplantation Market Challenges
Table 15. Allogeneic Stem Cell Transplantation Market Restraints
Table 16. Global Allogeneic Stem Cell Transplantation Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Allogeneic Stem Cell Transplantation Market Share by Players (2020-2025)
Table 18. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2024)
Table 19. Ranking of Global Top Allogeneic Stem Cell Transplantation Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Transplantation Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Allogeneic Stem Cell Transplantation, Headquarters and Area Served
Table 22. Global Key Players of Allogeneic Stem Cell Transplantation, Product and Application
Table 23. Global Key Players of Allogeneic Stem Cell Transplantation, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Allogeneic Stem Cell Transplantation Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2020-2025)
Table 27. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2026-2031)
Table 29. Global Allogeneic Stem Cell Transplantation Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2020-2025)
Table 31. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2026-2031)
Table 33. North America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2026-2031) & (US$ Million)
Table 48. Mesoblast Limited Company Details
Table 49. Mesoblast Limited Business Overview
Table 50. Mesoblast Limited Allogeneic Stem Cell Transplantation Product
Table 51. Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 52. Mesoblast Limited Recent Development
Table 53. Gamida Cell Ltd. Company Details
Table 54. Gamida Cell Ltd. Business Overview
Table 55. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product
Table 56. Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 57. Gamida Cell Ltd. Recent Development
Table 58. Novartis International AG Company Details
Table 59. Novartis International AG Business Overview
Table 60. Novartis International AG Allogeneic Stem Cell Transplantation Product
Table 61. Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 62. Novartis International AG Recent Development
Table 63. Cellectis SA Company Details
Table 64. Cellectis SA Business Overview
Table 65. Cellectis SA Allogeneic Stem Cell Transplantation Product
Table 66. Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 67. Cellectis SA Recent Development
Table 68. Magenta Therapeutics Inc. Company Details
Table 69. Magenta Therapeutics Inc. Business Overview
Table 70. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 71. Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 72. Magenta Therapeutics Inc. Recent Development
Table 73. Fate Therapeutics Inc. Company Details
Table 74. Fate Therapeutics Inc. Business Overview
Table 75. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 76. Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 77. Fate Therapeutics Inc. Recent Development
Table 78. Cynata Therapeutics Limited Company Details
Table 79. Cynata Therapeutics Limited Business Overview
Table 80. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product
Table 81. Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 82. Cynata Therapeutics Limited Recent Development
Table 83. Kiadis Pharma N.V Company Details
Table 84. Kiadis Pharma N.V Business Overview
Table 85. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product
Table 86. Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 87. Kiadis Pharma N.V Recent Development
Table 88. Takeda Pharmaceutical Company Limited Company Details
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product
Table 91. Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Limited Recent Development
Table 93. JCR Pharmaceuticals Co., Ltd. Company Details
Table 94. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 95. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product
Table 96. JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 97. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 98. Pluristem Therapeutics Inc. Company Details
Table 99. Pluristem Therapeutics Inc. Business Overview
Table 100. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 101. Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 102. Pluristem Therapeutics Inc. Recent Development
Table 103. Celularity Inc. Company Details
Table 104. Celularity Inc. Business Overview
Table 105. Celularity Inc. Allogeneic Stem Cell Transplantation Product
Table 106. Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 107. Celularity Inc. Recent Development
Table 108. Lineage Cell Therapeutics Inc. Company Details
Table 109. Lineage Cell Therapeutics Inc. Business Overview
Table 110. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 111. Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 112. Lineage Cell Therapeutics Inc. Recent Development
Table 113. Nohla Therapeutics Inc. Company Details
Table 114. Nohla Therapeutics Inc. Business Overview
Table 115. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 116. Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 117. Nohla Therapeutics Inc. Recent Development
Table 118. Orchard Therapeutics Plc Company Details
Table 119. Orchard Therapeutics Plc Business Overview
Table 120. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product
Table 121. Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2020-2025) & (US$ Million)
Table 122. Orchard Therapeutics Plc Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Allogeneic Stem Cell Transplantation Picture
Figure 2. Global Allogeneic Stem Cell Transplantation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Allogeneic Stem Cell Transplantation Market Share by Type: 2024 VS 2031
Figure 4. Unmodified Stem Cell Transplant Features
Figure 5. T-cell Depleted Transplant Features
Figure 6. Cord Blood Transplant Features
Figure 7. Donor Lymphocyte Infusion Features
Figure 8. Global Allogeneic Stem Cell Transplantation Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Allogeneic Stem Cell Transplantation Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Ambulatory Surgical Center Case Studies
Figure 12. Others Case Studies
Figure 13. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 14. Global Allogeneic Stem Cell Transplantation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Allogeneic Stem Cell Transplantation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Allogeneic Stem Cell Transplantation Market Share by Region: 2024 VS 2031
Figure 17. Global Allogeneic Stem Cell Transplantation Market Share by Players in 2024
Figure 18. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Transplantation Revenue in 2024
Figure 20. North America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 22. United States Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 26. Germany Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Allogeneic Stem Cell Transplantation Market Share by Region (2020-2031)
Figure 34. China Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 42. Mexico Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Share by Country (2020-2031)
Figure 46. Turkey Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Allogeneic Stem Cell Transplantation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Mesoblast Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 50. Gamida Cell Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 51. Novartis International AG Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 52. Cellectis SA Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 53. Magenta Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 54. Fate Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 55. Cynata Therapeutics Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 56. Kiadis Pharma N.V Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 57. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 58. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 59. Pluristem Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 60. Celularity Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 61. Lineage Cell Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 62. Nohla Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 63. Orchard Therapeutics Plc Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232